By Kapitall : Do you consider a stock's sales trends when comparing names? For ideas on how to start your own sales analysis, we ran a screen. We began by screening the healthcare sector for stocks with high growth prospects, with 5-year projected EPS growth above 15%. We then screened these names
By Kapitall : Do you check company sales trends when evaluating stocks? Since most companies rely on sales as their primary source of profit, a sales analysis should be high on the list. For ideas on how to look at a company's sales, we ran a screen. We began with stocks of the healthcare sector ...
By Brian Marckx : Q4 2011 Results Summary Revenue On March 5, 2012, Trinity Biotech ( TRIB ) reported financial results for the fourth quarter ending December 31, 2011. Revenue of $20.0 million was about 7% less …
By Jessica King Holden : With IBB up 15% year to date, gains in the healthcare sector have kept the headway started in 2012 as more companies are moving into earnings. Vivus' ( VVUS ) Qnexa FDA nod gained mainstream headlines and netted biotech savvy investors over 100% gains. Positive surprises in
… singling them out for negative comment, but I’ve written recently about Trinity Biotech ( TRIB ) so let’s use their numbers as an example: TRIB has an annual net income run-rate of Complete Story »
By Wexboy : Trinity Biotech ( TRIB ) Mkt Price: $9.57 Mkt Cap: $203.1 mio P/E: 13.5 Ex ..... hemoglobin disorders, and to detect, monitor and control diabetes. TRIB ’s HQ is in Ireland, with Irish and U.S. facilities, and quoted …
I prefer wind energy, but with oil at high prices, this is interesting too. http:// trib .com/opinion/columns/small-modular-reactors-look-promising/article_5a6032a4-4eb1-5100-90cc-38e439082288.html
By Brian Marckx : Q2 RESULTS Revenue On July 21, 2011 Trinity Biotech ( TRIB ) reported financial results for the second quarter ending June 30, 2011. Revenue of $19.5 million was about 1% less than …
One of the burbs of Chicago just opened a casino. The Trib has some pics of people standing in line to get in. Doesn't look like any of the 1% are in line. Gigi
Nicholas Pardini submits: This is the first article of a dividends by sectors series, which will scout out the best quality companies in a given sector that pay greater than a 3% dividend yield. Within the healthcare industry, the big pharmaceutical companies offer the best yields. With relatively